{"id":272028,"date":"2020-10-15T03:41:55","date_gmt":"2020-10-15T07:41:55","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=272028"},"modified":"2020-10-16T03:44:03","modified_gmt":"2020-10-16T07:44:03","slug":"russia-approves-second-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/10\/15\/russia-approves-second-covid-19-vaccine\/","title":{"rendered":"Russia approves second Covid-19 vaccine"},"content":{"rendered":"<figure id=\"attachment_265058\" aria-describedby=\"caption-attachment-265058\" style=\"width: 718px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/Russia-to-start-Covid-19-vaccine-production-in-2-weeks.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-265058\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/Russia-to-start-Covid-19-vaccine-production-in-2-weeks-718x1024.jpg\" alt=\"\" width=\"718\" height=\"1024\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/Russia-to-start-Covid-19-vaccine-production-in-2-weeks-718x1024.jpg 718w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/Russia-to-start-Covid-19-vaccine-production-in-2-weeks-210x300.jpg 210w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/08\/Russia-to-start-Covid-19-vaccine-production-in-2-weeks-768x1095.jpg 768w\" sizes=\"auto, (max-width: 718px) 100vw, 718px\" \/><\/a><figcaption id=\"caption-attachment-265058\" class=\"wp-caption-text\">On August 11, Russia issued a temporary conditional registration for a vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. (Pexels photo)<\/figcaption><\/figure>\n<p><strong>MOSCOW<\/strong>\u00a0\u2013 Russian President Vladimir Putin said Wednesday a second coronavirus disease 2019 (Covid-19) vaccine has been granted regulatory approval.<\/p>\n<p>Putin said the vaccine, EpiVakKorona, was registered at the Vector State Research Center in Novosibirsk.<\/p>\n<p>On August 11, Russia issued a temporary conditional registration for a vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.<\/p>\n<p>Conditional registration is issued for medicine considered vital to protect public health in an emergency, such as the Covid-19 pandemic.<\/p>\n<p>Russia on Wednesday reported 14,231 new cases of Covid-19, setting a new record for daily infections across the country.<\/p>\n<p>The new cases raised the tally to more than 1.34 million and the death toll reached 23,305 with 239 more fatalities, according to health authorities.<\/p>\n<p>The total number of recoveries in the country has crossed 1.3 million as 7,920 more patients got over the disease in the past 24 hours.<em><strong>\u00a0(Anadolu)<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MOSCOW\u00a0\u2013 Russian President Vladimir Putin said Wednesday a second coronavirus disease 2019 (Covid-19) vaccine has been granted regulatory approval. Putin &hellip;<\/p>\n","protected":false},"author":44,"featured_media":265058,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,17],"tags":[],"class_list":["post-272028","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-w","mauthors-anadolu","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/272028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=272028"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/272028\/revisions"}],"predecessor-version":[{"id":272029,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/272028\/revisions\/272029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/265058"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=272028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=272028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=272028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}